When it comes to groundbreaking innovations within the healthcare industry, one may not initially think of pharma companies' contracting and pricing strategies. After all, there are new life-changing drug therapies, orphan drug therapies, and preemptive diagnostic capabilities developed more and more. But are contracting and pricing strategies tied to patient outcomes quickly becoming the new-age innovation to transform healthcare?